Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan
Po Lin Lin, Yen Wen Wu, Chao Feng Lin, Hung I. Yeh, Wei Ting Chang, Min Ji Charng, Po Hsun Huang, Chih-Chan Lin, Tsung Hsien Lin, Wei Wen Lin, I. Chang Hsieh, Feng Yu Kuo, Ching Pei Chen, Yi Heng Li
Dive into the research topics of 'Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan'. Together they form a unique fingerprint.